On July 27, CMBC CAPITAL fell 8.86% in regular trading, trading at HK$2.41/share, with turnover of HK$13.05 million.
On the news front, Smart Fish Wealthlink announced on July 24 the proposed sale of 31.78 million CMBC CAPITAL shares for a total consideration of HK$95.35 million, expecting to record a loss of approximately HK$25.2 million. The discount disposal by a shareholder further intensified bearish market sentiment. The shares were sold to two individual buyers at prices below Smart Fish Wealthlink's carrying value.
Additionally, the stock has been under sustained pressure since July 21 after the IPO prospectus of Puqi Pharmaceutical — for which CMBC CAPITAL served as joint sponsor — expired. On July 24, the stock plunged over 40% intraday before paring losses. Although Puqi Pharmaceutical re-filed its application with the Hong Kong Stock Exchange on July 24, accumulated losses remain significant, and short-term market confidence recovery requires time. CMBC CAPITAL previously reported a 197.73% year-on-year increase in net profit to HK$151 million, largely driven by securities underwriting and sponsorship fee income, making the sponsorship setback a particular concern for revenue sustainability.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments